ePrints
Items where Author is "Luo, X"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 9.
Croft, H, Chen, JM, Wang, R, Mo, G, Luo, S, Luo, X, He, L, Gonsamo, A, Arabian, J, Zhang, Y, Simic-Milas, A, Noland, TL, He, Y, Homolova, L, Malenovsky, Z 
ORCID: 0000-0002-1271-8103, Yi, Q, Beringer, J, Amiri, R, Hutley, L, Arellano, P, Stahl, C and Bonal, D 2020
, 'The global distribution of leaf chlorophyll content'
, Remote Sensing of Environment, vol. 236
, pp. 1-15
, doi: https://doi.org/10.1016/j.rse.2019.111479.
ORCID: 0000-0002-1271-8103, Yi, Q, Beringer, J, Amiri, R, Hutley, L, Arellano, P, Stahl, C and Bonal, D 2020
, 'The global distribution of leaf chlorophyll content'
, Remote Sensing of Environment, vol. 236
, pp. 1-15
, doi: https://doi.org/10.1016/j.rse.2019.111479.
Croft, H, Chen, JM, Wang, R, Mo, G, Luo, S, Luo, X, He, L, Gonsamo, A, Arabian, J, Zhang, Y, Simic-Milas, A, Noland, TL, He, Y, Homolova, L, Malenovsky, Z ORCID: 0000-0002-1271-8103, Yi, Q, Beringer, J, Amiri, R, Hutley, L, Arellano, P, Stahl, C and Bonal, D 2020
, 'The global distribution of leaf chlorophyll content'
, Remote Sensing of Environment, vol. 236
, pp. 1-15
, doi: https://doi.org/10.1016/j.rse.2019.111479.
ORCID: 0000-0002-1271-8103, Yi, Q, Beringer, J, Amiri, R, Hutley, L, Arellano, P, Stahl, C and Bonal, D 2020
, 'The global distribution of leaf chlorophyll content'
, Remote Sensing of Environment, vol. 236
, pp. 1-15
, doi: https://doi.org/10.1016/j.rse.2019.111479.
Liu, Q, Luo, X, Zhou, Z ORCID: 0000-0002-0835-8686, Peng, L, Yi, L, Wan, X, Tan, C and Zeng, X 2021
, 'PD-L1 test-based strategy with Nivolumab as the second-line treatment in advanced NSCLC: A cost-effectiveness analysis in China'
, Frontiers in Oncology, vol. 11
, pp. 1-11
, doi: https://doi.org/10.3389/fonc.2021.745493.
ORCID: 0000-0002-0835-8686, Peng, L, Yi, L, Wan, X, Tan, C and Zeng, X 2021
, 'PD-L1 test-based strategy with Nivolumab as the second-line treatment in advanced NSCLC: A cost-effectiveness analysis in China'
, Frontiers in Oncology, vol. 11
, pp. 1-11
, doi: https://doi.org/10.3389/fonc.2021.745493.
Liu, Q, Zhou, Z ORCID: 0000-0002-0835-8686, Luo, X, Yi, L, Peng, L, Wan, X, Tan, C and Zeng, X 2022
, 'Cost-effectiveness of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy in metastatic non-squamous and squamous NSCLC patients With PD-L1 expression ≥ 50%'
, Frontiers in Pharmacology, vol. 12
, pp. 1-10
, doi: https://doi.org/10.3389/fphar.2021.803626.
ORCID: 0000-0002-0835-8686, Luo, X, Yi, L, Peng, L, Wan, X, Tan, C and Zeng, X 2022
, 'Cost-effectiveness of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy in metastatic non-squamous and squamous NSCLC patients With PD-L1 expression ≥ 50%'
, Frontiers in Pharmacology, vol. 12
, pp. 1-10
, doi: https://doi.org/10.3389/fphar.2021.803626.
Liu, Q, Zhou, Z ORCID: 0000-0002-0835-8686, Luo, X, Yi, L, Peng, L, Wan, X, Tan, C and Zeng, X 2021
, 'First-line ICI monotherapies for advanced non-small-cell lung cancer patients with PD-L1 of at least 50%: A cost-effectiveness analysis'
, Frontiers in Pharmacology, vol. 12
, pp. 1-10
, doi: https://doi.org/10.3389/fphar.2021.788569.
ORCID: 0000-0002-0835-8686, Luo, X, Yi, L, Peng, L, Wan, X, Tan, C and Zeng, X 2021
, 'First-line ICI monotherapies for advanced non-small-cell lung cancer patients with PD-L1 of at least 50%: A cost-effectiveness analysis'
, Frontiers in Pharmacology, vol. 12
, pp. 1-10
, doi: https://doi.org/10.3389/fphar.2021.788569.
Liu, Q, Zhou, Z ORCID: 0000-0002-0835-8686, Luo, X, Yi, L, Peng, L, Wan, X, Tan, C and Zeng, X 2021
, 'First-line ICI monotherapies for advanced non-small-cell lung cancer patients with PD-L1 of at least 50%: A cost-effectiveness analysis'
, Frontiers in Pharmacology, vol. 12
, pp. 1-10
, doi: https://doi.org/10.3389/fphar.2021.788569.
ORCID: 0000-0002-0835-8686, Luo, X, Yi, L, Peng, L, Wan, X, Tan, C and Zeng, X 2021
, 'First-line ICI monotherapies for advanced non-small-cell lung cancer patients with PD-L1 of at least 50%: A cost-effectiveness analysis'
, Frontiers in Pharmacology, vol. 12
, pp. 1-10
, doi: https://doi.org/10.3389/fphar.2021.788569.
Luo, X, Liu, Q, Zhou, Z ORCID: 0000-0002-0835-8686, Yi, L, Peng, L, Wan, X, Zeng, X, Tan, C and Li, S 2022
, 'Cost-effectiveness of Bevacizumab Biosimilar LY01008 combined with chemotherapy as first-line treatment for chinese patients with advanced or recurrent nonsquamous non-small cell lung cancer'
, Frontiers in Pharmacology, vol. 13
, doi: https://doi.org/10.3389/fphar.2022.832215.
ORCID: 0000-0002-0835-8686, Yi, L, Peng, L, Wan, X, Zeng, X, Tan, C and Li, S 2022
, 'Cost-effectiveness of Bevacizumab Biosimilar LY01008 combined with chemotherapy as first-line treatment for chinese patients with advanced or recurrent nonsquamous non-small cell lung cancer'
, Frontiers in Pharmacology, vol. 13
, doi: https://doi.org/10.3389/fphar.2022.832215.
Luo, X, Zhou, Z ORCID: 0000-0002-0835-8686, Zeng, X and Liu, Q 2022
, 'The cost-effectiveness of tislelizumab plus chemotherapy for locally advanced or metastatic nonsquamous non-small cell lung cancer'
, Frontiers in Pharmacology, vol. 13
, doi: https://doi.org/10.3389/fphar.2022.935581.
ORCID: 0000-0002-0835-8686, Zeng, X and Liu, Q 2022
, 'The cost-effectiveness of tislelizumab plus chemotherapy for locally advanced or metastatic nonsquamous non-small cell lung cancer'
, Frontiers in Pharmacology, vol. 13
, doi: https://doi.org/10.3389/fphar.2022.935581.
Rao, J, Fan, D, Wu, S, Lin, D, Zhang, H, Ye, S, Luo, X, Wang, L, Yang, J, Pang, M, Zhang, J, Xia, Q, Yang, X, Wang, W, Fu, Y, Liu, Y, Guo, X and Liu, Z 2018
, 'Trend and risk factors of low birth weight and macrosomia in south China, 2005-2017: A retrospective observational study'
, Scientific Reports, vol. 8, no. 1
, pp. 1-8
, doi: https://doi.org/10.1038/s41598-018-21771-6.